| abstract |
A preventive and/or therapeutic agent for lung diseases exhibiting neutrophilic inflammation, for example, chronic obstructive pulmonary disease (COPD), pulmonary emphysema, chronic bronchitis, acute respiratory distress syndrome (ARDS) and acute lung injury (ALI), which preventive and/or therapeutic agent comprises, as an active ingredient, 4-[(3,5-dichloro-4-pyridyl)carbamoyl]-7-methoxy-2-(4-methylpiperazin-1-ylcarbonyl)benzofuran of the formula: (I) or a pharmacologically acceptable salt thereof. |